Metoclopramide Versus Ketorolac for Tension-type Headache
NCT ID: NCT01011673
Last Updated: 2018-05-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
123 participants
INTERVENTIONAL
2009-11-30
2012-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Metoclopramide for Post Traumatic Headache
NCT03220958
Ketamine v. Ketorolac for Management of Generalized Tension Type Headache
NCT03221569
Valproate Versus Ketorolac Versus Metoclopramide
NCT01267864
Droperidol Versus Metoclopramide + Diphenhydramine for the Treatment of Primary Headaches
NCT01406860
Oral Medications for the Management of Acute Migraine Headache in the Emergency Department
NCT05983354
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ketorolac
Ketorolac 30mg IVSS
Ketorolac
ketorolac 30mg IVSS
Metoclopramide
metoclopramide 20mg IVSS + diphenhydramine 25mg IVSS
Metoclopramide
metoclopramide 20mg IVSS + diphenhydramine 25mg IVSS
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Metoclopramide
metoclopramide 20mg IVSS + diphenhydramine 25mg IVSS
Ketorolac
ketorolac 30mg IVSS
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Secondary cause of headache
21 Years
64 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Montefiore Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Benjamin W. Friedman, MD
Associate professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Montefiore Medical Center
The Bronx, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Friedman BW, Adewunmi V, Campbell C, Solorzano C, Esses D, Bijur PE, Gallagher EJ. A randomized trial of intravenous ketorolac versus intravenous metoclopramide plus diphenhydramine for tension-type and all nonmigraine, noncluster recurrent headaches. Ann Emerg Med. 2013 Oct;62(4):311-318.e4. doi: 10.1016/j.annemergmed.2013.03.017. Epub 2013 Apr 6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09-08-249
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.